MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$4,225,106
Other income
$22,507
Loss from operations
-$4,239,076
Interest expense
$8,537
Total operating
expenses
$4,239,076
Research & development
$2,985,873
General &
administrative
$1,253,203
Back
Back
Income Statement
source: myfinsight.com
Curanex Pharmaceuticals Inc (CURX)
Curanex Pharmaceuticals Inc (CURX)